sur BIOSYNEX (EPA:ALBIO)
BIOSYNEX SA victim of a cyberattack
BIOSYNEX, a company active in the field of health diagnostics, announced that it suffered a cyberattack between July 31 and August 2, 2026. In response to this incident, BIOSYNEX immediately implemented measures to limit the impact of this intrusion and strengthened the security of its IT platforms.
A thorough investigation is underway to assess the extent of the attack. At this stage, the compromised data appears to be limited to business information. BIOSYNEX has notified the authorities, including the CNIL (French Data Protection Authority), and continues to keep its partners informed of the situation.
The company's operations were reportedly not affected by this incident. A complaint has been filed with the judicial authorities.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BIOSYNEX